Literature DB >> 1369278

Expression of human lymphotoxin in Namalwa KJM-1 cells adapted to serum-free medium.

H Miyaji1, N Harada, T Mizukami, S Sato, N Fujiyoshi, S Itoh.   

Abstract

A Namalwa cell line, KJM-1, which was adapted to serum-free medium is thought to be a good host cell line for recombinant DNA technology. We previously reported the expression of human beta-interferon (beta-IFN) in Namalwa KJM-1 (Miyaji, 1989a). The utility of Namalwa KJM-1 for expression of foreign genes was further examined. As a target gene to be expressed, human lymphotoxin (hLT) cDNA was used. It was engineered for expression in Namalwa KJM-1 using a simian virus 40 (SV40)-based expression vector pAGE107 (Miyaji, 1989a). It contains all components necessary for the expression of cDNA in mammalian cells. The expression vector was introduced into Namalwa KJM-1 by electroporation. Among the transformants, clone 7 was further examined for the expression of hLT in serum-free medium. The production level of hLT was augmented with the increase of the cell density. Thus it was further indicated that Namalwa KJM-1 is useful for production of foreign gene products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1369278     DOI: 10.1007/bf00148809

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  9 in total

1.  Establishment of stable mouse myeloma cells constitutively secreting human tissue-type plasminogen activator.

Authors:  U H Weidle; P Buckel
Journal:  Gene       Date:  1987       Impact factor: 3.688

2.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

Review 3.  Lymphotoxin.

Authors:  N L Paul; N H Ruddle
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

4.  The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes.

Authors:  H Dorai; G P Moore
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

5.  Establishment of Namalva cell lines which grow continuously in glutamine-free medium.

Authors:  S Hosoi; H Mioh; C Anzai; S Sato; N Fujiyoshi
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

6.  Human tumor necrosis factor. Production, purification, and characterization.

Authors:  B B Aggarwal; W J Kohr; P E Hass; B Moffat; S A Spencer; W J Henzel; T S Bringman; G E Nedwin; D V Goeddel; R N Harkins
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

7.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.

Authors:  P W Gray; B B Aggarwal; C V Benton; T S Bringman; W J Henzel; J A Jarrett; D W Leung; B Moffat; P Ng; L P Svedersky
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

8.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium.

Authors:  H Miyaji; T Mizukami; S Hosoi; S Sato; N Fujiyoshi; S Itoh
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

  9 in total
  4 in total

1.  Optimization of cell culture conditions for production of biologically active proteins.

Authors:  S Hosoi; H Miyaji; M Satoh; T Kurimoto; A Mihara; N Fujiyoshi; S Itoh; S Sato
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

2.  Optimization of cell culture conditions for G-CSF (granulocyte-colony stimulating factor) production by genetically engineered Namalwa KJM-1 cells.

Authors:  S Hosoi; K Murosumi; K Sasaki; M Satoh; H Miyaji; M Hasegawa; S Itoh; T Tamaoki; S Sato
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

3.  Stable production of recombinant pro-urokinase by human lymphoblastoid Namalwa KJM-1 cells: host-cell dependency of the expressed-protein stability.

Authors:  M Satoh; S Hosoi; H Miyaji; S Itoh; S Sato
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Efficient expression of human beta-interferon in Namalwa KJM-1 cells adapted to serum-free medium by a dhfr gene coamplification method.

Authors:  H Miyaji; N Harada; T Mizukami; S Sato; N Fujiyoshi; S Itoh
Journal:  Cytotechnology       Date:  1990-09       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.